Stockscreener 앱 받기
4.45
2.20%
-0.10
시간 외 거래:
4.50
0.05
+1.12%
Capsovision Inc 주식(CV)의 최신 뉴스
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com South Africa
CapsoVision Raises $600,000 Through IPO Overallotment - TipRanks
CapsoVision prices $27.5M IPO - MSN
Why Did CapsoVision Plunge 10.45% After IPO Pricing? - AInvest
CapsoVision's IPO: A Pill to Swallow in the GI Diagnostics Market? - AInvest
CapsoVision Soars 40.31% on IPO Debut - AInvest
CapsoVision Closes $27.5 Million IPO; Shares Rebound - MarketScreener
CapsoVision, Inc. Successfully Closes Initial Public Offering Raising $27.5 Million - Nasdaq
CapsoVision Announces Closing of Initial Public Offering - GlobeNewswire
CapsoVision Stocks: Bursting Bubbles or Rising Stars? - StocksToTrade
CapsoVision’s Wild Ride: Why This Med-Tech Newcomer Is Turning Heads on Nasdaq - RagingBull
CapsoVision’s Rollercoaster: Risk or Reward? - timothysykes.com
CapsoVision, Inc.(NasdaqCM: CV) added to NASDAQ Composite Index - MarketScreener
CapsoVision begins trading on Nasdaq at $5 per share, declines since - Investing.com India
CV IPO NewsMedical device maker CapsoVision prices IPO at $5, the low end of the range - renaissancecapital.com
CapsoVision Prices 5.5M Share IPO at $5/sh - Investing.com Australia
CapsoVision Prices IPO at $5 per Share - MarketScreener
CapsoVision, Inc. Announces Initial Public Offering Pricing of $5.00 per Share - Nasdaq
Med-tech IPOs gain steam going into Q3 - BioWorld MedTech
CapsoVision Aims to Swallow GI Imaging Market – $28M Nasdaq Debut Eyes AI-Powered Diagnostic Future - Minichart
CapsoVision, Inc. (CV) Announces July 2nd IPO - Defense World
CapsoVision IPO: Key Details and Insights into the Company’s Market Debut - AInvest
Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech
CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology (Pending:CV) - Seeking Alpha
Three med-tech IPOs on the horizon - BioWorld MedTech
Capsule endoscopy developer CapsoVision files $30M IPO - Fierce Biotech
CapsoVision Inc’s IPO: A Groundbreaking Play in Medical Imaging? - AInvest
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Earns FDA Clearance to Continue Remote Ingestion, Further Expanding Access and Comfort for Patients - The Malaysian Reserve
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Receives FDA Clearance for Pediatric Use, Offering a Comfortable, Child-Friendly Solution for Young Patients - PR Newswire
Global Smart Pills Technologies Industry is poised for a substantial surge, targeting US$ 6176 Milli - PharmiWeb.com
Capsule Endoscopes Market Size (2022-2030)Advin Healthcare, CapsoVision Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Medtronic Plc and Olympus Corporation - Yahoo Finance
CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19 - PR Newswire
Ingestible Sensors Market Is Likely to Experience a Tremendous - openPR.com
UPDATE -- CapsoVision, Inc. Announces CE Mark for the Use - GlobeNewswire
CapsoVision Enhances CapsoCam Plus Capsule Endoscopy System With CapsoCloud - Medical Design & Outsourcing
CapsoVision, Inc. Announces FDA 510(k) Clearance For CapsoCam Plus - Med Device Online
1.15%
0.17%
자본화:
|
볼륨(24시간):